The global demand for Antidepressants Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Medications used for treating clinical depression are identified as antidepressants. Antidepressants help to relieve symptoms of depression such as anxiety, feeling very down, restlessness, suicidal thoughts, sleep problems and prevent their recurrence. These drugs boost levels of certain chemicals called neurotransmitters in the brain, namely serotonin, and noradrenaline, which are related to one's emotion and mood. The nerve cells present inside the brain uses the chemicals to send signals. There are various types of antidepressants, and some of them are serotonin and norepinephrine reuptake inhibitors (SNRIs), selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), dopamine reuptake blocker, and tetracyclic antidepressants.
Market Dynamics
The global antidepressant market is set to witness an upward curve due to the rising incidence of depression. At present, the ongoing Covid-19 pandemic will drive the overall market growth. The worldwide crisis is expected to have a negative impact on an individual's mental health due to fear of getting infected by the virus and fear of losing near and dear ones, increasing job insecurity and social isolation. Other factors that contribute to its market growth are the development of novel biologics, awareness related to depression, and the rise in the aging population. However, the side effects related to antidepressants may hinder its market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of antidepressants. The growth and trends of antidepressants industry provide a holistic approach to this study.
Market Segmentation
This section of the antidepressants market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Depression Disorder
- Major Depressive Disorder
- Obsessive-Compulsive Disorder
- Generalized Anxiety Disorder
- Panic Disorder
- Others
By Product
- Tricyclic Antidepressants
- Selective Serotonin Reuptake Inhibitors
- Serotonin-Norepinephrine Reuptake Inhibitors
- Monoamine Oxidase Inhibitors
- Serotonin Antagonist And Reuptake Inhibitors
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Antidepressants market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Antidepressants Market Share by Region (Representative Graph)
Know more about this report: Download free sample
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the antidepressants market include Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly And Co., Glaxosmithkline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., And Takeda Pharmaceutical Co. Ltd.. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.